Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
22,163,711
-
Total 13F shares
-
57,923,797
-
Share change
-
-4,735,192
-
Total reported value
-
$69,503,540
-
Put/Call ratio
-
2.9%
-
Price per share
-
$1.20
-
Number of holders
-
65
-
Value change
-
-$6,740,043
-
Number of buys
-
24
-
Number of sells
-
49
Institutional Holders of Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (ADVM) as of Q2 2022
As of 30 Jun 2022,
Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (ADVM) was held by
65 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
57,923,797 shares.
The largest 10 holders included
FMR LLC, MORGAN STANLEY, Sonic Fund II, L.P., Versant Venture Management, LLC, VANGUARD GROUP INC, BlackRock Inc., Artal Group S.A., RA CAPITAL MANAGEMENT, L.P., JPMORGAN CHASE & CO, and TWO SIGMA ADVISERS, LP.
This page lists
67
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.